-
-
-
-
-
-
-
Zipalertinib trial data to be presented at IASLC lung cancer conference
-
-
-
-
-
-
-
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
-
-
-
-
-
-
-
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
-
-
-
-
-
68,885 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


